Trials / Not Yet Recruiting
Not Yet RecruitingNCT06953024
Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Nova Scotia Health Authority · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Accepted
Summary
This study aims to validate the percent agreement of the INSTI Multiplex Human Immunodeficiency (HIV) 1/2 syphilis antibody (Ab) test (INSTI POCT) when used as a self-test by patients compared to conventional serologic testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | INSTI HIV/syphilis Point of Care Self-Test Administration | The INSTI Human Immunodeficiency Virus (HIV)/syphilis POCT is a rapid, single-use, flow-through immunoassay that is Health Canada-approved as a screening test for detecting antibodies to HIV1/2 and syphilis using a fingerstick blood sample. |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-10-01
- Completion
- 2026-12-01
- First posted
- 2025-05-01
- Last updated
- 2025-05-01
Source: ClinicalTrials.gov record NCT06953024. Inclusion in this directory is not an endorsement.